Studies Approved by the hSCRO

All Human Stem Cell Research Oversight Committee (hSCRO)-approved protocols, including protocols that do not require Committee approval, for which the departing investigator is designated the PI must be terminated, or an alternate PI should be designated via a protocol modification form. The hSCRO Office (412) 383-1768 can provide further details about these procedures.